These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26966525)

  • 1. Long-acting somatostatin analogues provide significant beneficial effect in patients with refractory small bowel angiodysplasia: Results from a proof of concept open label mono-centre trial.
    Holleran G; Hall B; Breslin N; McNamara D
    United European Gastroenterol J; 2016 Feb; 4(1):70-6. PubMed ID: 26966525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia.
    Bon C; Aparicio T; Vincent M; Mavros M; Bejou B; Raynaud JJ; Zampeli E; Airinei G; Sautereau D; Benamouzig R; Michopoulos S
    Aliment Pharmacol Ther; 2012 Sep; 36(6):587-93. PubMed ID: 22831465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis.
    Goltstein LCMJ; Grooteman KV; Rocco A; Holleran G; Frago S; Salgueiro PS; Aparicio T; Scaglione G; Chetcuti Zammit S; Prados-Manzano R; Benamouzig R; Nardone G; McNamara D; Benallaoua M; Michopoulos S; Sidhu R; Kievit W; Drenth JPH; van Geenen EJM
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):922-932. PubMed ID: 34508668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural history of small bowel angiodysplasia.
    Holleran G; Hall B; Zgaga L; Breslin N; McNamara D
    Scand J Gastroenterol; 2016; 51(4):393-9. PubMed ID: 26540240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre, open-label, randomised, parallel-group, superiority study to compare the efficacy of octreotide therapy 40 mg monthly versus standard of care in patients with refractory anaemia due to gastrointestinal bleeding from small bowel angiodysplasias: a protocol of the OCEAN trial.
    Grooteman KV; van Geenen EJ; Drenth JP
    BMJ Open; 2016 Sep; 6(9):e011442. PubMed ID: 27619827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory Anaemia Secondary to Small Bowel Angioectasias - Comparison between Endotherapy Alone versus Combination with Somatostatin Analogues.
    Chetcuti Zammit S; Sidhu R; Sanders D
    J Gastrointestin Liver Dis; 2017 Dec; 26(4):369-374. PubMed ID: 29253051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases.
    Nardone G; Compare D; Scarpignato C; Rocco A
    Dig Liver Dis; 2014 Aug; 46(8):688-94. PubMed ID: 24893688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-balloon enteroscopy: preliminary experience in patients with obscure gastrointestinal bleeding or chronic abdominal pain.
    May A; Nachbar L; Wardak A; Yamamoto H; Ell C
    Endoscopy; 2003 Dec; 35(12):985-91. PubMed ID: 14648408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: an overview and systematic review of prospective observational studies.
    Brown C; Subramanian V; Wilcox CM; Peter S
    Dig Dis Sci; 2010 Aug; 55(8):2129-34. PubMed ID: 20393879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial.
    Goltstein LCMJ; Grooteman KV; Bernts LHP; Scheffer RCH; Laheij RJF; Gilissen LPL; Schrauwen RWM; Talstra NC; Zuur AT; Braat H; Hadithi M; Brouwer JT; Nagengast WB; Oort FA; Tenthof van Noorden J; Kievit W; van Geenen EJM; Drenth JPH
    Gastroenterology; 2024 Apr; 166(4):690-703. PubMed ID: 38158089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results with lanreotide in patients with recurrent gastrointestinal angiodysplasias bleeding or obscure gastrointestinal bleeding. Benefits in efficacy and procedures consumption.
    Frago S; Alcedo J; Martín Pena-Galo E; Lázaro M; Ollero L; de la Llama N
    Scand J Gastroenterol; 2018 Dec; 53(12):1496-1502. PubMed ID: 30621520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract.
    Orsi P; Guatti-Zuliani C; Okolicsanyi L
    Dig Liver Dis; 2001 May; 33(4):330-4. PubMed ID: 11432511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Somatostatin analogues in the treatment of bleeding GI-angiodysplasias].
    Boesby L; Christensen NJ; Kristensen LO
    Ugeskr Laeger; 2008 Mar; 170(11):958. PubMed ID: 18397628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia.
    Scaglione G; Pietrini L; Russo F; Franco MR; Sorrentini I
    Aliment Pharmacol Ther; 2007 Sep; 26(6):935-42. PubMed ID: 17767478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome after argon plasma coagulation of small-bowel lesions using double-balloon enteroscopy in patients with mid-gastrointestinal bleeding.
    May A; Friesing-Sosnik T; Manner H; Pohl J; Ell C
    Endoscopy; 2011 Sep; 43(9):759-65. PubMed ID: 21544778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lanreotide in the management of small bowel angioectasias: seven-year data from a tertiary centre.
    Chetcuti Zammit S; Sanders DS; Sidhu R
    Scand J Gastroenterol; 2017 Sep; 52(9):962-968. PubMed ID: 28506132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of patients undergoing capsule and double-balloon enteroscopy for identification and treatment of small-bowel vascular lesions: a prospective, multicenter study.
    Rahmi G; Samaha E; Vahedi K; Delvaux M; Gay G; Lamouliatte H; Filoche B; Saurin JC; Ponchon T; Rhun ML; Coumaros D; Bichard P; Manière T; Lenain E; Chatellier G; Cellier C
    Endoscopy; 2014 Jul; 46(7):591-7. PubMed ID: 24830401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and therapeutic impact of double-balloon enteroscopy (DBE) in a series of 100 patients with suspected small bowel diseases.
    Cazzato IA; Cammarota G; Nista EC; Cesaro P; Sparano L; Bonomo V; Gasbarrini GB; Gasbarrini A
    Dig Liver Dis; 2007 May; 39(5):483-7. PubMed ID: 17379586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Octreotide in the treatment of angiodysplasia in patients with advanced chronic renal failure].
    Rivera M; Lucero J; Guerrero A; Márquez JL; Montes R; Suñer M; Ruiz A; Valdivia MA; Mateos J
    Nefrologia; 2005; 25(3):332-5. PubMed ID: 16053016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues.
    Wolin EM; Jarzab B; Eriksson B; Walter T; Toumpanakis C; Morse MA; Tomassetti P; Weber MM; Fogelman DR; Ramage J; Poon D; Gadbaw B; Li J; Pasieka JL; Mahamat A; Swahn F; Newell-Price J; Mansoor W; Öberg K
    Drug Des Devel Ther; 2015; 9():5075-86. PubMed ID: 26366058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.